{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:48:21Z","timestamp":1781938101313,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.obpill.2022.100039","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T21:55:13Z","timestamp":1666734913000},"page":"100039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Obesity Pillars roundtable: Excessive weight reduction with highly effective anti-obesity medications (heAOMs)"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-1408","authenticated-orcid":false,"given":"Harold Edward","family":"Bays","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karli","family":"Burridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Fitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2022.100039_bib1","article-title":"Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022","author":"Bays","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc16-2427","article-title":"Coadministration of canagliflozin and phentermine for weight management in overweight and obese individuals without diabetes: a randomized clinical trial","volume":"40","author":"Hollander","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2022.100039_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/oby.20584","article-title":"Evaluation of phentermine and topiramate versus phentermine\/topiramate extended-release in obese adults","volume":"21","author":"Aronne","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2022.100039_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.obpill.2022.100039_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A\u00a0randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.obpill.2022.100039_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.obpill.2022.100039_bib7","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/oby.20309","article-title":"A\u00a0randomized, phase 3 trial of naltrexone SR\/bupropion SR on weight and obesity-related risk factors (COR-II)","volume":"21","author":"Apovian","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2022.100039_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 Years with OrlistatA randomized controlled trial","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.obpill.2022.100039_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/oby.22347","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of Gelesis100: a novel nonsystemic oral hydrogel for weight loss","volume":"27","author":"Greenway","year":"2019","journal-title":"Obesity"},{"key":"10.1016\/j.obpill.2022.100039_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.obpill.2022.100039_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2022.100034","article-title":"Thirty obesity myths, misunderstandings, and\/or oversimplifications: an obesity medicine association (OMA) clinical practice statement (CPS) 2022","volume":"3","author":"Bays","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/osp4.364","article-title":"Experience and expectations of patients on weight loss: the learning health system network experience","volume":"5","author":"DeJesus","year":"2019","journal-title":"Obesity Science & Practice"},{"key":"10.1016\/j.obpill.2022.100039_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2021.100004","article-title":"Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022","volume":"1","author":"Fitch","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2022.100014","article-title":"Behavior, motivational interviewing, eating disorders, and obesity management technologies: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022","volume":"2","author":"Freshwater","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.soard.2007.02.010","article-title":"Association between support group attendance and weight loss after Roux-en-Y gastric bypass","volume":"4","author":"Song","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.obpill.2022.100039_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.soard.2010.07.013","article-title":"Positive relationship between support group attendance and one-year postoperative weight loss in gastric banding patients","volume":"7 1","author":"Kaiser","year":"2011","journal-title":"Surg Obes Relat Dis : official journal of the American Society for Bariatric Surgery"},{"key":"10.1016\/j.obpill.2022.100039_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2022.100026","article-title":"Cancer and obesity: an obesity medicine association (OMA) clinical practice statement (CPS) 2022","volume":"3","author":"Lazarus","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib18","first-page":"627","article-title":"Impact of weight loss on cancer patients' quality of life at the beginning of the chemotherapy","volume":"29","author":"\u00c1lvaro Sanz","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.obpill.2022.100039_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2022.100017","article-title":"Concomitant medications, functional foods, and supplements: an obesity medicine association (OMA) clinical practice statement (CPS) 2022","volume":"2","author":"Tondt","year":"2022","journal-title":"Obesity Pillars"},{"key":"10.1016\/j.obpill.2022.100039_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1503\/cmaj.1031527","article-title":"An approach to the management of unintentional weight loss in elderly people","volume":"172","author":"Alibhai","year":"2005","journal-title":"CMAJ (Can Med Assoc J) : Canadian Medical Association journal = journal de l'Association medicale canadienne"},{"key":"10.1016\/j.obpill.2022.100039_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.obpill.2022.100039_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.31887\/DCNS.2011.13.1\/rshelton","article-title":"Inflammation in depression: is adiposity a cause?","volume":"13","author":"Shelton","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.obpill.2022.100039_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2021.105017","article-title":"Plasma levels of ghrelin and GLP-1, but not leptin or amylin, respond to a psychosocial stressor in women and men","volume":"134","author":"McKay","year":"2021","journal-title":"Horm Behav"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368122000304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368122000304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:14:27Z","timestamp":1757409267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368122000304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":23,"alternative-id":["S2667368122000304"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2022.100039","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Pillars roundtable: Excessive weight reduction with highly effective anti-obesity medications (heAOMs)","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2022.100039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100039"}}